The availability of direct-acting antiviral drugs may enable eradication of hepatitis C virus and improve outcomes.
Latest Chronic Kidney Disease (CKD) News
A small set of serum protein biomarkers combined with clinical variables, enhances the prediction of renal function loss over a wide range of baseline eGFR values.
New guidelines suggest aiming for a systolic pressure less than 150 mm Hg in hypertensive individuals aged 60 or older.
Metformin is associated with reduced all-cause mortality in patients with CKD, CHF, or CLD with hepatic impairment.
Kidney disease patients who regularly consumed produce, legumes, cereals, whole grains, and fiber had a 27% lower risk of death compared with those who did not.
Lower eGFR and higher ACR are associated with an elevated risk of infection-related hospitalization and infection-related death.
Urine haptoglobin, is a novel biomarker and complement to urine albumin for predicting kidney damage in patients with type 2 diabetes.
Multidisciplinary care program alleviates the much larger cost of dialysis.
Reducing sodium consumption to about 2,500 mg daily was associated with albuminuria improvement.
The researchers found that kidney function worsened faster in smokers compared to nonsmokers and those who quit.
Since constipation is common, the study findings may be important for public health.
The association is independent of albumin-to-creatinine ratio, according to investigators.
Current smoking was linked with higher risks for lung cancer and upper aerodigestive cancer by 9 and 5 times, respectively.
Tight control of inflammation in RA may provide additional benefits for preventing the development of CKD.
Study confirms the noninferiority of semaglutide.
PPI use was associated with 10% increased odds of CKD and 76% increased odds of death.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)